Anaxomics Biotech S.L

Anaxomics is AI biotech company that use cutting-edge technologies based on Systems Biology to overcome challenges in drug discovery and development process. Were specialized in In Silico Clinical Trials, which offer a highly efficient way to optimize clinical trials. Our proprietary technology, Therapeutic Performance Mapping Systems Technology (TPMS), enables to build mathematical models that elucidate the mechanisms of action of drugs and identify biomarkers to monitor in the trials. With TPMS, we also provide early profiling of safety issues and off-target effects, helping to optimize clinical trials and speed up the drug development process. Our team of experts is dedicated...

In silico clinical trial ,artificial intelligence,systems biology,drug discovery,real world evidence,mechanism of action,biomarkers,precision medicine,data science,combinatory therapies,new indications,safety prediction,machine leraning,repurposing,and real world evidence

Anaxomics biotech s.l operates in the Biotechnology research industry.

Anaxomics biotech s.l's revenue is 11m - 100m

Anaxomics biotech s.l has 11 - 50 employees.